Form 4 for STE Steris
Accepted 2025-10-03 00:00:00 ET · period of report 2025-10-01 · accession 0001628280-25-044116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-03 | 2025-10-01 | STE | Fraser Mary Clare | SVP, Chief HRO | F - Tax | $0.00 | -207 | 12.9K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-10-01 | F | D | 207 | $0.00 | 12,882 | D | — | — | (F1) 207 shares were withheld from the 692 restricted shares that vested on October 1, 2025. These 201 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 692 ordinary shares were awarded to Ms. Fraser on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2025. (F2) As of October 1, 2025, 8,886 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,313 on June 1, 2026; 2,028 on June 2, 2026; 2,040 on June 4, 2027 and 2,505 on June 5, 2028. |